Here’s some detail on a few of the side effects this drug may or may not cause. You may wonder how often certain side effects occur with this drug, or whether certain side effects pertain to it. * This serious side effect is explained in more detail below in “Side effect details.” Side effect details Clinical trials have shown that when a LABA is used in combination with an ICS, using the LABA does not increase the risk of asthma-related death and hospitalization. But in Trelegy, it’s combined with fluticasone, an inhaled corticosteroid (ICS), and umeclidinium, an anticholinergic. Vilanterol, an ingredient in Trelegy Ellipta, is a LABA. Note: Long-acting beta2-agonists (LABAs) are known to increase the risk of asthma-related death and hospitalization if they’re taken alone.
If you would like to report to the FDA a side effect you’ve had with Trelegy Ellipta, you can do so through MedWatch. Note: The Food and Drug Administration (FDA) tracks side effects of drugs they have approved.
TRELEGY ICS LABA LAMA INFORMATION HOW TO
They can give you tips on how to deal with any side effects that may be bothersome. These lists don’t include all possible side effects.įor more information on the possible side effects of Trelegy Ellipta, talk with your doctor or pharmacist. The following lists contain some of the key side effects that may occur while taking Trelegy Ellipta. Trelegy Ellipta can cause mild or serious side effects. It’s the first FDA-approved medication containing three active drugs that can be used once a day for either COPD or asthma.
More recently, in 2020, the drug was approved to treat asthma. In 2017, the Food and Drug Administration (FDA) approved Trelegy Ellipta to treat COPD. Effectivenessįor information about the effectiveness of Trelegy Ellipta, see the “ Trelegy Ellipta for COPD” and “ Trelegy Ellipta for asthma” sections below. Trelegy Ellipta is approved for use in adults ages 18 years and older. This medication is taken as one inhalation (puff) of Trelegy Ellipta once each day. The word “Ellipta” refers to the specific type of dry powder inhaler that contains the drug. “Trelegy” is the name of the medication inside the inhaler.
fluticasone, which is an inhaled corticosteroid (ICS).It contains these three active drugs that help relieve breathing symptoms of COPD and asthma: Trelegy Ellipta is a combination medication. For more information about Trelegy Ellipta’s approved uses, see the “ Trelegy Ellipta for COPD” and “ Trelegy Ellipta for asthma” sections below. However, Trelegy Ellipta isn’t approved for use as a rescue inhaler to ease sudden breathing problems caused by either COPD or asthma. chronic obstructive pulmonary disease (COPD), which is a group of lung conditions that include emphysema and chronic bronchitis.It’s FDA-approved for the long-term maintenance treatment of: Trelegy Ellipta is a brand-name prescription medication.
0 kommentar(er)
